IP Library Granted Patent US 9,011,665
Granted Patent B2
US 9,011,665 · App. 10/591,793 · Granted Apr 21, 2015

Metal implants

Inventors: Martin Edward Lee Pickford (Southampton, GB); David Richard Lewis (Abingdon, GB); Andrew Derek Turner (Abingdon, GB)
Assignee: Accentus Medical Limited
A61L27/32C25D11/26C23C28/042A61L27/047A61L27/06A61L27/306A61L27/54A61L27/56A61L2300/104A61L2300/404A61L2400/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,011,665
App. No.
10/591,793
Granted
Apr 21, 2015
Kind
B2
Abstract

A metal implant for use in a surgical procedure is provided with a surface layer that is integral with the metal substrate, and which incorporates a biocidal material. The surface layer is grown by anodizing at a voltage between 50 and 150 V, and the biocidal material incorporated in it by ion exchange. This produces a significantly harder surface than anodizing at low voltage, and generates pits containing ion-absorbing material.

Claims (11)

1. A titanium metal implant comprising a metal substrate for use in a surgical procedure, said implant having a mirror finish surface layer integral with said metal substrate and incorporating a biocidal metal material, said implant comprising as said surface layer an anodized hard layer including pits in said hard layer, the hard layer having a thickness between 0.07 microns and 0.7 microns and having a coloured appearance determined by the thickness, said pits being filled with a softer and more porous material than the hard layer, wherein the softer and more porous material comprises hydrous titanium dioxide, and wherein the surface layer comprises a surface area, and wherein said pits are of a diameter about 5 microns and said pits occupy between 15 and 20% of the surface area of the surface layer, said pits extending through said hard layer into said metal substrate, said hard layer and said pits including ions of said biocidal metal material as a result of ion exchange, with said more porous material in the pits having absorbed biocidal metal material to a larger extent than said hard layer, and wherein a phosphate matrix is present at said surface layer of said metal substrate, and wherein the phosphate matrix comprises biocidal metal ions.

2. A titanium metal implant according to claim 1 , wherein titanium is present in said substrate at at least 75% by weight.

3. A titanium metal implant according to claim 2 , wherein the titanium is present as pure titanium or as a titanium alloy.

4. A titanium metal implant according to claim 1 , wherein the biocidal metal ions are selected from the group consisting of: silver, gold, platinum, ruthenium and palladium.

5. A titanium metal implant according to claim 1 , wherein the hard layer is 0.14 micrometers thick.

6. A titanium metal implant according to claim 5 , wherein the pits in the hard layer have a depth of approximately 0.4 micrometers.

7. A titanium metal implant according to claim 1 , wherein other elements are present in said surface layer, selected from the group consisting of: copper, tin, antimony, lead, bismuth and zinc.

8. A method of treating a titanium metal implant comprised of a metal substrate for use in a surgical procedure, said method including the steps of polishing a surface of the implant to obtain a mirror finish, anodising the implant for forming a surface layer integral with said metal substrate, rinsing the anodised implant, and then performing ion exchange so as to incorporate ions of a biocidal metal into the surface layer, characterised in that said method comprises anodising the implant for a period of more than 30 minutes so as to generate the surface layer, wherein the anodising comprises applying a voltage between 50 volts and 150 volts to said surface of said implant in an electrolyte comprising phosphoric acid of concentration between 5% and 20% by weight, wherein said surface retains a mirror finish after said anodising step,

and wherein the anodising is performed for sufficient time to initially generate a dense hard surface layer and then also to generate shallow pits in the surface layer which are filled with a somewhat softer and more porous material comprising hydrous titanium dioxide, wherein the surface layer comprises a surface area, and wherein said pits are of a diameter about 5 microns and occupy between 15% and 20% of the surface area of the surface layer, said pits extending through said hard layer into said metal substrate, wherein, in the ion exchange step, said more porous material in the pits absorbs biocidal metal to a larger extent than said hard layer.

9. A method as claimed in claim 8 , wherein said biocidal metal is silver.

10. A method as claimed in claim 8 , wherein chloride ions are added to the electrolyte, so the electrolyte comprises chloride ions at a concentration no more than 500 ppm.

Assignments (4)
CHANGE OF NAME Recorded Mar 9, 2015
From: ACCENTUS PLC
To: ACCENTUS MEDICAL PLC
Reel/Frame 035118/0660 →
CHANGE OF NAME Recorded Mar 9, 2015
From: ACCENTUS MEDICAL PLC
To: ACCENTUS MEDICAL LIMITED
Reel/Frame 035159/0369 →
EXCLUSIVE LICENSE AGREEMENT Recorded Jun 26, 2013
From: ACCENTUS MEDICAL PLC
To: ZIMMER, INC.
Reel/Frame 030710/0423 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2007
From: PICKFORD, MARTIN EDWARD LEE; LEWIS, DAVID RICHARD; TURNER, ANDREW DEREK
To: ACCENTUS PLC
Reel/Frame 019352/0284 →
Priority Claims (1)
GB 0405680.0 · Mar 13, 2004 · national
Continuity (1)
Related Publication 20070181221A1 · Aug 9, 2007